## Clinical Presentation and Diagnosis **Key Point:** This neonate presents with classic neonatal hyperammonemia (380 µmol/L) with metabolic acidosis, poor feeding, lethargy, and hypotonia — the hallmark of acute urea cycle defect in the first week of life. ### Diagnostic Clue: Elevated Urinary Orotic Acid The **markedly elevated urine orotic acid** is the pathognomonic finding that points to **OTC deficiency**. This occurs because: 1. Carbamoyl phosphate accumulates when OTC cannot convert it to citrulline 2. Excess carbamoyl phosphate is shunted into the pyrimidine synthesis pathway 3. This produces excess orotic acid, which is excreted in urine **High-Yield:** OTC deficiency is the **most common urea cycle disorder** (~50% of cases) and the **only X-linked form** — important for genetic counseling. ### Biochemical Basis of Hyperammonemia ```mermaid flowchart TD A[Protein catabolism] --> B[Glutamate deaminase] B --> C[Free ammonia] C --> D[Carbamoyl phosphate synthetase I] D --> E[Carbamoyl phosphate] E -->|OTC enzyme| F[Citrulline] F --> G[Argininosuccinate] G --> H[Arginine] H --> I[Urea] I --> J[Excreted] E -->|No OTC| K[Accumulation]:::urgent K --> L[Shunt to pyrimidine pathway]:::urgent L --> M[Excess orotic acid]:::outcome M --> N[Elevated urine orotic acid]:::outcome ``` ### Why Plasma Amino Acids Show Glutamine and Alanine Elevation - **Glutamine:** Ammonia is captured by glutamine synthetase (Gln ← Glu + NH₃), causing hyperglutaminemia - **Alanine:** Secondary to muscle proteolysis and transamination in response to hyperammonemia ### Metabolic Acidosis Mechanism The respiratory alkalosis expected from hyperammonemia is masked by metabolic acidosis (pH 7.32, HCO₃⁻ 18) due to: - Impaired renal ammonia excretion - Accumulation of organic acids - Hyperglutaminemia-induced renal dysfunction **Clinical Pearl:** Normal liver function tests rule out acute hepatic encephalopathy or fulminant hepatitis — this is a primary metabolic disorder, not secondary hyperammonemia. ## Differential Diagnosis of Urea Cycle Defects | Enzyme Defect | Urine Orotic Acid | Plasma Citrulline | Plasma Arginine | Key Finding | |---|---|---|---|---| | **OTC deficiency** | **↑↑↑ (Markedly)** | Low | Low | Pyrimidine shunt | | CPS I deficiency | Normal/↓ | Low | Low | No orotic acid ↑ | | Argininosuccinate lyase | ↑ (Mild) | ↑ | Low | Argininosuccinate in urine | | Arginase | Normal | ↑↑ | ↑↑ | Hyperargininemia | **High-Yield:** The **elevated urine orotic acid is PATHOGNOMONIC for OTC deficiency** — this is the single most discriminating test. ## Management Implications 1. **Acute management:** Protein restriction, arginine supplementation, sodium benzoate (conjugates glutamine → hippurate) 2. **Genetic:** X-linked inheritance → affected males; carrier females may have symptoms 3. **Prognosis:** Early diagnosis and treatment can prevent neurological damage [cite:Robbins 10e Ch 3; Lehninger Principles of Biochemistry Ch 22] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.